An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone made a short, free checklist you can use to see if you might qualify for a GLP-1 weight-loss program before you fill out a long intake form. The checklist promises to cover the five main things clinics often look at: body mass index (BMI) cutoffs, qualifying medical conditions, factors that would disqualify you, and whether semaglutide or tirzepatide might be a better fit. The creator says it takes about two minutes to complete and links to futurweightloss.com/glp1-eligibility-checklist. GLP-1s are a class of medicines used for weight loss and diabetes. Semaglutide (brand names like Ozempic and Wegovy) and tirzepatide (brand name Zepbound or Mounjaro for diabetes) are two examples. In plain terms: these drugs act like a hormone your gut makes after eating that tells your brain you're full and slows how fast your stomach empties. Clinics and prescribers use simple rules — like BMI thresholds and other health conditions — to decide who is a candidate. The checklist claims to summarize the typical eligibility rules used by many clinics. That includes BMI cutoffs (how your weight compares to height), certain medical conditions that might qualify you even with a lower BMI, things that would rule you out, and guidance on whether semaglutide or tirzepatide tends to be chosen. The snippet doesn’t give study data or new research — it’s a practical screening tool, not a clinical trial. So there’s no scientific result to evaluate here, just a convenience resource that reflects how some providers screen patients. Why this matters: deciding whether to pursue these medications can feel confusing. A short checklist can save time by helping you know if it’s worth starting an application or talking to a clinician. People considering prescription weight-loss medicines, or those curious if they meet common criteria, may find it useful. It can also help you gather the right information before a clinic asks for it. Caveats and risks: the checklist is not medical advice. It likely reflects typical clinic rules but may not match every provider or current regulatory guidelines. Whether you actually get a prescription depends on a medical evaluation, labs, and a prescriber’s judgment. These drugs have side effects and some people shouldn’t take them; only a clinician can assess that. Also, I can’t verify the checklist’s accuracy or completeness from the snippet alone, so treat it as a starting point, not a final decision. Bottom line: the free checklist is a quick way to see if you might pass common screening steps for GLP-1 weight-loss programs, but you still need a medical visit to confirm safety and eligibility.
Source: r/Semaglutide